THC Overzicht aandelen
Produces and sells medical and recreational cannabis in Canada.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 1/6 |
| Toekomstige groei | 0/6 |
| Prestaties in het verleden | 0/6 |
| Financiële gezondheid | 1/6 |
| Dividenden | 0/6 |
THC Biomed Intl Ltd. Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | CA$0.02 |
| 52 Week Hoogtepunt | CA$0.045 |
| 52 Week Laag | CA$0.01 |
| Bèta | 0.38 |
| 11 maand verandering | 0% |
| 3 maanden verandering | 0% |
| 1 Jaar Verandering | -50.00% |
| 33 jaar verandering | -85.19% |
| 5 jaar verandering | -92.98% |
| Verandering sinds IPO | -99.81% |
Recent nieuws en updates
Recent updates
Does THC Biomed Intl (CSE:THC) Have A Healthy Balance Sheet?
Oct 11
Is THC Biomed Intl (CSE:THC) Weighed On By Its Debt Load?
Jun 26Is THC Biomed Intl (CSE:THC) Weighed On By Its Debt Load?
Mar 13Is THC Biomed Intl (CSE:THC) Using Too Much Debt?
Aug 30We Think THC Biomed Intl (CSE:THC) Has A Fair Chunk Of Debt
Mar 25Does THC Biomed Intl (CSE:THC) Have A Healthy Balance Sheet?
Dec 02Is THC Biomed Intl (CSE:THC) Using Too Much Debt?
Jun 01Analysts Expect Breakeven For THC Biomed Intl Ltd. (CSE:THC) Before Long
Apr 06Would THC Biomed Intl (CSE:THC) Be Better Off With Less Debt?
Jan 08Rendement voor aandeelhouders
| THC | CA Pharmaceuticals | CA Markt | |
|---|---|---|---|
| 7D | 0% | -4.7% | -1.5% |
| 1Y | -50.0% | 17.0% | 21.1% |
Rendement versus industrie: THC underperformed the Canadian Pharmaceuticals industry which returned 84.7% over the past year.
Rendement versus markt: THC underperformed the Canadian Market which returned 4.9% over the past year.
Prijsvolatiliteit
| THC volatility | |
|---|---|
| THC Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.9% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.5% |
| 10% least volatile stocks in CA Market | 2.9% |
Stabiele aandelenkoers: THC's share price has been volatile over the past 3 months.
Volatiliteit in de loop van de tijd: Insufficient data to determine THC's volatility change over the past year.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 2012 | 35 | John Miller | thcbiomed.com |
THC Biomed Intl Ltd. Samenvatting
| THC fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | CA$3.28m |
| Inkomsten(TTM) | -CA$3.67m |
| Inkomsten(TTM) | CA$2.23m |
1.5x
P/S-verhouding-0.9x
Koers/WinstverhoudingIs THC overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| THC resultatenrekening (TTM) | |
|---|---|
| Inkomsten | CA$2.23m |
| Kosten van inkomsten | CA$3.39m |
| Brutowinst | -CA$1.16m |
| Overige uitgaven | CA$2.51m |
| Inkomsten | -CA$3.67m |
Laatst gerapporteerde inkomsten
Apr 30, 2023
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | -0.022 |
| Brutomarge | -52.14% |
| Nettowinstmarge | -164.79% |
| Schuld/Eigen Vermogen Verhouding | 91.8% |
Hoe presteerde THC op de lange termijn?
Bekijk historische prestaties en vergelijking